METHYLDOPATE HYDROCHLORIDE Drug Patent Profile

When do Methyldopate Hydrochloride patents expire, and when can generic versions of Methyldopate Hydrochloride launch?

Methyldopate Hydrochloride is a drug marketed by Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral. and is included in ten NDAs.

The generic ingredient in METHYLDOPATE HYDROCHLORIDE is methyldopate hydrochloride. There is one drug master file entry for this compound. Additional details are available on the methyldopate hydrochloride profile page.

Summary for METHYLDOPATE HYDROCHLORIDE

US Patents:	0
Applicants:	7
NDAs:	10
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	388
DailyMed Link:	METHYLDOPATE HYDROCHLORIDE at DailyMed

US Patents and Regulatory Information for METHYLDOPATE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abraxis Pharm	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070652-001	Jun 3, 1986		DISCN	No	No
Hospira	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070849-001	Jun 19, 1987		DISCN	No	No
Hospira	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070691-001	Jun 19, 1987		DISCN	No	No
Marsam Pharms Llc	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	071812-001	Dec 22, 1987		DISCN	No	No
Am Regent	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	071279-001	Oct 2, 1987		DISCN	No	No
Baxter Hlthcare	METHYLDOPATE HYDROCHLORIDE	methyldopate hydrochloride	INJECTABLE;INJECTION	070291-001	Jul 1, 1986		DISCN	No	No